Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):95-103. doi: 10.1002/ccd.25635. Epub 2014 Oct 4.

Abstract

With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the SCAI publications committee concisely summarizes and provides editorial commentary on the most important trials from recent, large international meetings. The intent is to provide this summary every six months to allow quick assimilation of trial results into interventional practice. © 2014 Wiley Periodicals, Inc.

Keywords: antithrombotics; myocardial infarction; peripheral arterial disease; review; stents; valvular heart disease.

Publication types

  • Review

MeSH terms

  • Cardiac Catheterization*
  • Cardiovascular Diseases / diagnosis*
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / therapy*
  • Catheterization, Peripheral*
  • Clinical Trials as Topic*
  • Diagnostic Techniques, Cardiovascular*
  • Endovascular Procedures*
  • Evidence-Based Medicine
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Percutaneous Coronary Intervention*
  • Predictive Value of Tests
  • Treatment Outcome

Substances

  • Fibrinolytic Agents